Lupin eyes foreign acquisitions | business | Hindustan Times
Today in New Delhi, India
Apr 26, 2017-Wednesday
-°C
New Delhi
  • Humidity
    -
  • Wind
    -

Lupin eyes foreign acquisitions

business Updated: May 26, 2010 21:23 IST
Sachin Kumar

The Rs 16,000-crore pharma major Lupin is looking for acquisitions in emerging markets like South Africa, Turkey and Philippines.

The company, now the eighth-largest generic drug maker by revenue in the US, is planning to grow inorganically. “We are indeed actively considering several of these proposals,” said Ramesh Swaminathan, president (finance & planning), Lupin.

Lupin may also use its subsidiaries for acquisition. It bought Kyowa Pharmaceutical in Japan in 2007, Pharma Dynamics in South Africa and Hormosan Pharma in Germany in 2008 and a majority stake in Multicare Pharmaceuticals of Philippines in 2009.